This is a single center study that uses both between-group comparisons and correlational analyses to establish biomarkers of dysmyelination and cognitive impairment in Psychotic Spectrum Disorders using imaging and neuropsychological assays.The study will provide non-invasive biomarkers of cognitive dysfunction in Psychotic Spectrum Disorder.
Study Type
OBSERVATIONAL
Enrollment
139
The NIMH-Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) is a consensus battery that is considered state-of-the art in the evaluation of cognitive skills for schizophrenia research.(Burton et al., 2013, Harvey, 2014) The complete cognitive battery takes about one hour to administer, and is comprised of 10 subtests measuring seven essential domains of function, with very good reliability and validity.(Nuechterlein 2008, August et al., 2012) The MATRICS subtests have been incorporated into the cognitive battery described below, with supplementary subtests included where indicated within each domain.
New York University School of Medicine
New York, New York, United States
DKI(metrics RDextra, faxon, and ADextra) Metrics
To compare DKI metrics (faxon, RDextra, and ADextra) in patients with SZ or BP, their unaffected siblings (SIB), and healthy comparison control (HC) subjects
Time frame: 6 Years
Magnetic Resonance Spectroscopy will be employed to obtain quantitative metrics of choline (Cho)
Choline Concentration (1H-MRS)
Time frame: 1 Hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.